Profilo
Lei Fang is currently the Vice President at Lepu Biopharma Co., Ltd. and the General Manager at CtM Bio Co., Ltd. Prior to these roles, Dr. Fang worked as the Director of Research & Development at I-MAB Biopharma Co., Ltd. from 2016 to 2020.
Dr. Fang also served as a Director at Third Venture Biopharma (Nanjing) Co., Ltd. Dr. Fang holds a doctorate degree from the Chinese Academy of Sciences and an undergraduate degree from Hebei University, which was conferred in 2004.
Posizioni attive di Lei Fang
| Società | Posizione | Inizio |
|---|---|---|
| LEPU BIOPHARMA CO., LTD. | Corporate Officer/Principal | 10/12/2020 |
CtM Bio Co., Ltd. | Amministratore Delegato | - |
Precedenti posizioni note di Lei Fang
| Società | Posizione | Fine |
|---|---|---|
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology Operates as biotechnology company focuses on cancer immunity and autoimmune disease treatment | Direttore Tecnico/Scientifico/R&S | 01/04/2020 |
Third Venture Biopharma (Nanjing) Co., Ltd. | Direttore/Membro del Consiglio | - |
Formazione di Lei Fang
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Chinese Academy of Sciences
Chinese Academy of Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hebei University
Hebei University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology Operates as biotechnology company focuses on cancer immunity and autoimmune disease treatment | Health Technology |
Lepu Biopharma Co., Ltd.
Lepu Biopharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
CtM Bio Co., Ltd. | |
Third Venture Biopharma (Nanjing) Co., Ltd. |
















